-
Real-World Treatment Patterns of Metastatic EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC) Patients from the Integra Connect Database
Mar 10, 2025, 14:00 PM -
What Proportion of the Total Value Generated by New Drugs Accrues to Manufacturers? A Review of Empirical Estimates of Producer Surplus
Mar 10, 2025, 14:00 PM -
Global Analysis of the Epidemiological Burden of Osteoarthritis based on Data from the Global Burden of Disease Study
Mar 10, 2025, 14:00 PM -
Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US
Mar 10, 2025, 14:00 PM -
A Simple and Practical Guide to Implementing Generalized Risk-Adjusted Cost-Effectiveness (GRACE): A Case Study in Non-Small Cell Lung Cancer
Mar 10, 2025, 14:00 PM -
Evolving Trends in Racial and Ethnic Disparities in Syphilis Prevalence Among People Who are Pregnant in The United States from 2016 To 2023
Mar 10, 2025, 14:00 PM -
Structured Evaluation of Oncology Real-World Data Quality for Practical Applications
Mar 10, 2025, 14:00 PM -
Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data
Mar 10, 2025, 14:00 PM -
Understanding Barriers to the Early Diagnosis of Mild Cognitive Impairment Due to Alzheimer's Disease from the Perspective of Physicians and Patients: Results from a Real-World Survey in Germany
Mar 10, 2025, 14:00 PM -
ActiveSLR: Optimizing efficiency in Systematic Literature Reviews with Artificial Intelligence
Mar 10, 2025, 14:00 PM -
Market Access as Defined by Professionals with Market Access Backgrounds - Scoping Review
Mar 10, 2025, 14:00 PM -
The Changing Impact of the Inflation Reduction Act on Payer Utilization Management- Insights from an Ongoing Quantitative Survey
Mar 10, 2025, 14:00 PM -
Modeling the Potential Public Health Impact and Cost-Effectiveness of BNT162b2 COVID-19 Adapted Booster Vaccination in Dominican Republic
Mar 10, 2025, 14:00 PM -
Healthcare Utilization and Costs in New Users of Once-Weekly GLP-1 Receptor Agonists vs Other Glucose-Lowering Therapies Among Medicare Beneficiaries With Type 2 Diabetes and Established Atherosclerotic Cardiovascular Disease
Mar 10, 2025, 14:00 PM -
Canada’s Evolving Market for Biosimilars and What It Means for Payers
Mar 10, 2025, 14:00 PM -
Mapping Health-Related Quality of Life (HRQoL) Measures to Preference Based Measures in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A systematic literature review
Mar 10, 2025, 14:00 PM -
A Contemporary Analysis of Utilization, Clinical Outcomes and Costs of Robotic-Assisted, Laparoscopic, and Open Partial Nephrectomy Using the National Inpatient Sample
Mar 10, 2025, 14:00 PM -
Adverse Events Associated With Recently Approved Alzheimer's Drugs: A Real-World Pharmacovigilance Study
Mar 10, 2025, 14:00 PM -
Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021
Mar 10, 2025, 14:00 PM -
Cost and Prevalence of Pre-Analytical Errors: A Narrative Review
Mar 10, 2025, 14:00 PM